News - Immunologicals, Roche

Filter

Current filters:

ImmunologicalsRoche

Popular Filters

Funding restrictions for rituximab and eltrombopag widened in New Zealand

Funding restrictions for rituximab and eltrombopag widened in New Zealand

20-02-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of proposals to widen…

Asia-PacificeltrombopagFinancialGlaxoSmithKlineHealthcareImmunologicalsNew ZealandPharmaceuticalrituximabRoche

UK’s NICE gives green light to Roche’s MabThera for GPA and MPA

UK’s NICE gives green light to Roche’s MabThera for GPA and MPA

24-01-2014

UK drugs watchdog the National Institute for Health and Care Excellence (NICE) today approved the use…

EuropeImmunologicalsMabTheraPharmaceuticalPricingRegulationRocheUK

Roche and immatics ink mega-million cancer vaccine and immunotherapy deal

Roche and immatics ink mega-million cancer vaccine and immunotherapy deal

13-11-2013

Germany’s privately-held immatics biotechnologies GmbH and Swiss drug major Roche have entered into…

BiotechnologyIMA942immatics biotechnologiesImmunologicalsOncologyRocheVaccines

Additional indications in Japan for Roche's Avastin and Astellas' Prograf

17-06-2013

Swiss drug major Roche (ROG: SIX) says that the Japanese Ministry of Health, Labor and Welfare (MHLW)…

Asia-PacificAstellas PharmaAvastinBiotechnologyImmunologicalsOncologyPharmaceuticalPrografRegulationRoche

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top